Background: Aorto-esophageal fistula is a rare but life-threatening condition most often linked to thoracic aortic aneurysms and significant upper gastrointestinal bleeding. Thoracic endovascular aortic repair (TEVAR) is a crucial, life-saving procedure, but delayed complications, such as secondary esophageal fistulas caused by endograft erosion, can develop. Prompt recognition and multidisciplinary management are vital for survival. Case Presentation: We describe a 57-year-old patient with cardiovascular comorbidities and a saccular thoracic aortic aneurysm, who initially presented with massive hematemesis, melena, and hemodynamic instability. Imaging showed an aorto-esophageal fistula. Emergency treatment included placing a fully covered esophageal stent followed by TEVAR. Three weeks later, he experienced fever, chest pain, and worsening dysphagia. Laboratory tests indicated elevated inflammatory markers and hypoalbuminemia. Computed tomography revealed a new retrocardial esophageal fistula at T9, caused by mechanical erosion from the thoracic endograft. Endoluminal vacuum-assisted closure (EndoVAC) therapy was performed, leading to clinical improvement and the return of esophageal function. Conclusions: This case highlights a rare instance of a delayed secondary esophageal fistula after TEVAR beneath a preexisting stent, likely due to chronic contact between the endograft and esophagus. Despite advancements in endoscopic therapy, secondary fistulas after TEVAR are associated with high morbidity. Early diagnosis, aggressive infection management, structured nutritional support, and a multidisciplinary approach are essential. Extraluminal or intraluminal vacuum-assisted closure offers a promising minimally invasive option for managing complex esophageal defects.
Background: Kidney transplant recipients are particularly vulnerable to severe infections because of chronic immunosuppression, impaired wound healing, repeated healthcare exposure, and the potential nephrotoxicity of antimicrobial therapy. We report a complex case of multidrug-resistant (MDR) sepsis in a kidney transplant recipient with two concomitant potential infectious sources: an infected sacral pressure ulcer and recurrent urinary tract infection. Case Presentation: A 31-year-old kidney transplant recipient developed traumatic paraplegia following a road traffic accident. Prolonged immobilization was complicated by a progressive sacral pressure ulcer and recurrent urinary tract infections in the setting of neurogenic bladder dysfunction. During hospitalization, wound and urinary cultures identified MDR Gram-negative organisms, including Klebsiella pneumoniae, Acinetobacter baumannii, and Proteus mirabilis. Blood cultures obtained during systemic deterioration were positive for K. pneumoniae. Diagnostic Assessment and Therapeutic Intervention: Severe systemic infection developed with hemodynamic deterioration and markedly elevated inflammatory biomarkers. Because both the urinary tract and infected sacral wound represented plausible infectious reservoirs, the primary source of bacteremia could not be established unequivocally. Management required extensive surgical debridement, negative pressure wound therapy with instillation, culture-directed antimicrobial therapy, and close monitoring of renal allograft function. Gentamicin was used as a culture-directed therapeutic option in the setting of limited antimicrobial alternatives and impaired renal function. Conclusions: This case illustrates the diagnostic and therapeutic complexity of severe MDR infection in kidney transplant recipients when multiple potential infectious sources coexist. Successful management required early source control, microbiological assessment, individualized antimicrobial selection, and multidisciplinary monitoring aimed at controlling infection while preserving renal allograft function.